Chakravarthy, Usha <br/><br/>
Bevacizumab for the treatment of neovascular age related macular degeneration.  [electronic resource] 

 -  BMJ (Clinical research ed.)  Jun 2010 
 - c2834 p.  digital 
<br/><br/> Publication Type: Comment; Editorial 
<br/><br/><label>ISSN: </label>1756-1833 
<br/><br/><label>Standard No.: </label>10.1136/bmj.c2834  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Humans<br/>Macular Degeneration--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Ranibizumab